The S&P 500 Index continued its strong downward trend last week, reaching its lowest level since December 17 last year. It ended the week at $6,740, down substantially from the year-to-date high of $7,000. Let’s explore some of the top catalysts for the SPY, IVV, and VOO ETFs this week. US inflation report A key
Telehealth platforms are becoming a gateway for access to blockbuster weight loss medicines. That shift became clearer on Monday after Novo Nordisk dropped its patent infringement lawsuit against digital health provider Hims & Hers. The Danish pharmaceutical company has instead agreed to allow Hims to distribute its branded semaglutide drugs through its telehealth platform. The
Lockheed Martin stock price has gone vertical since 2024 and is now hovering near its all-time high. LMT was trading at $671 on Friday, down slightly from the all-time high of $692. It remains about 66% from its lowest point in 2025, and this trend may continue as demand continues rising. Lockheed Martin to benefit
The dramatic escalation of the US-Iran conflict, marked by the recent blockade of the Strait of Hormuz, has sent shockwaves through global energy markets. While broad indices falter under the weight of heightened uncertainty, Indonesia Energy (INDO) has defied the gloom, staging an explosive and volatile rally. This microcap explorer – insulated geographically from immediate
Tesla stock (NASDAQ: TSLA) slipped about 2% on Friday, and the options market is leaning with the move, not against it. For a stock that lives on momentum and belief, the tone in derivatives is clear: traders aren’t calling for a crash, but they are paying up to protect against more downside as Tesla grinds
Mounting redemption requests across private credit funds are raising fresh questions about the resilience of one of the fastest-growing corners of the global debt market. BlackRock, the world’s largest asset manager, has limited withdrawals from one of its flagship private credit vehicles for the first time, underscoring growing investor unease as volatility spreads across financial
Day One Biopharmaceuticals (NASDAQ: DAWN) ripped higher on Friday morning after Servier signed a definitive agreement to acquire the California-based firm for about $2.5 billion in cash. Servier’s deal rewrites DAWN’s technical profile, valuing its shares at $21.5 each, which translates to a nearly 70% upside from its previous close. Following this explosive move to
Micron Technology shares fell on Friday as weakness in South Korean memory names weighed on sentiment and US investors awaited February jobs data. The moves come as US stocks remained in the red amid the Iran conflict, while South Korean memory giants Samsung Electronics and SK Hynix also declined on the Korea Exchange. Micron edges
In 2025, artificial intelligence moved from tech circles into everyday life. It showed up everywhere, from conversations at the dinner table, in questions about whether the next phone or washing machine would run on AI, and in emails from managers urging employees to learn how to use it. Suddenly, the technology was no longer abstract.
The surge in artificial intelligence investment is reshaping venture capital markets, but it is also concentrating funding in ways that may complicate progress for women founders. While female-founded startups in the United States raised a record amount of venture funding in 2025, much of the capital was concentrated in a handful of AI companies, highlighting